Clinical Trials for Covaxin on 6-12 Age Group to Start from Tomorrow
New Delhi: The All India Institute of Medical Sciences (AIIMS) Delhi will start clinical trials of Bharat Biotech's Covaxin for the 6-12 age group from Tuesday to evaluate the safety and efficacy of COVID-19 vaccine on children.
The…